COMBINATIONAL TARGETING OF HDAC6 AND PD-1/PD-L1 IMMUNE CHECKPOINT IN ARID1A-MUTATED OVARIAN CANCERS

被引：0
|
作者：
Fatkhutdinov, Nail [1 ,2 ]
Fukumoto, Takeshi [1 ]
Zhang, Rugang [1 ]
机构：
[1] Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA
[2] Kazan Fed Univ, Kazan, Russia
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TMIM-072
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [1] ARID1A-mutated ovarian cancers depend on HDAC6 activity
    Benjamin G. Bitler
    Shuai Wu
    Pyoung Hwa Park
    Yang Hai
    Katherine M. Aird
    Yemin Wang
    Yali Zhai
    Andrew V. Kossenkov
    Ana Vara-Ailor
    Frank J. Rauscher III
    Weiping Zou
    David W. Speicher
    David G. Huntsman
    Jose R. Conejo-Garcia
    Kathleen R. Cho
    David W. Christianson
    Rugang Zhang
    Nature Cell Biology, 2017, 19 : 962 - 973
  • [2] ARID1A-mutated ovarian cancers depend on HDAC6 activity
    Bitler, Benjamin G.
    Wu, Shuai
    Park, Pyoung Hwa
    Hai, Yang
    Aird, Katherine M.
    Wang, Yemin
    Zhai, Yali
    Kossenkov, Andrew V.
    Vara-Ailor, Ana
    Rauscher, Frank J., III
    Zou, Weiping
    Speicher, David W.
    Huntsman, David G.
    Conejo-Garcia, Jose R.
    Cho, Kathleen R.
    Christianson, David W.
    Zhang, Rugang
    NATURE CELL BIOLOGY, 2017, 19 (08) : 962 - +
  • [3] A key HDAC6 dependency of ARID1A-mutated ovarian cancer
    Altucci, Lucia
    NATURE CELL BIOLOGY, 2017, 19 (08) : 889 - 890
  • [4] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [5] A key HDAC6 dependency of ARID1A-mutated ovarian cancer
    Lucia Altucci
    Nature Cell Biology, 2017, 19 : 889 - 890
  • [6] PD-1/PD-L1 expression in BRCA1/2 mutated ovarian cancers
    Penn, C. A.
    Lester, J.
    Bohrer, K.
    Moon, C.
    Yearley, J.
    Karlan, B. Y.
    Walsh, C.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 33 - 33
  • [7] Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis
    Timmerman, John
    ONCOLOGY-NEW YORK, 2015, 29 (06): : 440 - 441
  • [8] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
    Peng, Zikun
    Li, Ming
    Li, Huayi
    Gao, Qinglei
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [9] Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas
    Ribatti, Domenico
    Cazzato, Gerardo
    Tamma, Roberto
    Annese, Tiziana
    Ingravallo, Giuseppe
    Specchia, Giorgina
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
    Tang, Qing
    Chen, Yun
    Li, Xiaojuan
    Long, Shunqin
    Shi, Yao
    Yu, Yaya
    Wu, Wanyin
    Han, Ling
    Wang, Sumei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345